Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary M Shaver

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
ACS Synthetic Biology|November 19, 2025
A Scalable Cell-Free Manufacturing Platform for Two-Step Bioproduction of Immunogenic Conjugate VaccinesDerek A Wong, Rochelle Aw, Sophia W Hulbert, et al.
Nature Communications|March 5, 2026
Design-driven optimization of low-cost reagent formulations for reproducible and high-yielding cell-free gene expressionMeagan L Olsen, Caroline E Copeland, Chad A Sundberg, et al.
AIDS (London, England)|February 3, 2022
Decreased hepatitis B virus vaccine response among HIV-positive infants compared with HIV-negative infants in BotswanaZachary M Shaver, Motswedi Anderson, Lynnette Bhebhe, et al.
BMC Infectious Diseases|October 24, 2019
Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional studyLynnette Bhebhe, Motswedi Anderson, Sajini Souda, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Development of cell-free platforms for discovering, characterizing, and engineering post-translational modificationsDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
Nature Communications|August 5, 2025
Characterizing and engineering post-translational modifications with high-throughput cell-free expressionDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
The Journal of Allergy and Clinical Immunology|June 29, 2026
Selective Elimination of Mast Cells via Siglec-6-Targeted Nanodelivery of Drug PayloadAriel Helms Thames, Clayton H Rische, Rebecca A Krier-Burris, et al.
BMC Research Notes|December 7, 2018
Attempted use of PACE for riboswitch discovery generates three new translational theophylline riboswitch side productsZachary M Shaver, Stephanie S Bent, Steven R Bilby, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
ACS Synthetic Biology|November 19, 2025
A Scalable Cell-Free Manufacturing Platform for Two-Step Bioproduction of Immunogenic Conjugate VaccinesDerek A Wong, Rochelle Aw, Sophia W Hulbert, et al.
Nature Communications|March 5, 2026
Design-driven optimization of low-cost reagent formulations for reproducible and high-yielding cell-free gene expressionMeagan L Olsen, Caroline E Copeland, Chad A Sundberg, et al.
AIDS (London, England)|February 3, 2022
Decreased hepatitis B virus vaccine response among HIV-positive infants compared with HIV-negative infants in BotswanaZachary M Shaver, Motswedi Anderson, Lynnette Bhebhe, et al.
BMC Infectious Diseases|October 24, 2019
Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional studyLynnette Bhebhe, Motswedi Anderson, Sajini Souda, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Development of cell-free platforms for discovering, characterizing, and engineering post-translational modificationsDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
Nature Communications|August 5, 2025
Characterizing and engineering post-translational modifications with high-throughput cell-free expressionDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
The Journal of Allergy and Clinical Immunology|June 29, 2026
Selective Elimination of Mast Cells via Siglec-6-Targeted Nanodelivery of Drug PayloadAriel Helms Thames, Clayton H Rische, Rebecca A Krier-Burris, et al.
BMC Research Notes|December 7, 2018
Attempted use of PACE for riboswitch discovery generates three new translational theophylline riboswitch side productsZachary M Shaver, Stephanie S Bent, Steven R Bilby, et al.
Pageof 1